Carboplatin/Durvalumab/Gemcitabine Regimen

Preferred Label : Carboplatin/Durvalumab/Gemcitabine Regimen;

NCIt synonyms : Carboplatin/Imfinzi/Gemcitabine; Carboplatin/Gemcitabine/Durvalumab; Carboplatin/Durvalumab/Gemcitabine; Carboplatin-Durvalumab-Gemcitabine; Carboplatin/Gemcitabine Plus Durvalumab; Gemcitabine/Carboplatin Plus Durvalumab; Durvalumab Plus Carboplatin/Gemcitabine;

NCIt definition : A regimen consisting of carboplatin, durvalumab, and gemcitabine that may be used in the treatment of non-small cell lung cancer (NSCLC).;

Détails

Origin ID

C213254;

chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Durvalumab [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients